-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Orthopoxvirus
- Others
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Virus Protease
- Antiviral intermediates
SARS-CoV-2-3CLpro-IN-3
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/2505241-13-2.gif)
| Category | SARS-CoV |
| CAS | 2505241-13-2 |
| Description | SARS-CoV-2 3CLpro-IN-3 (Compound 3d) is a SARS CoV-2 3CLpro inhibitor with antiviral, antibacterial and antifungal activities |
Product Information
| Synonyms | SARS-CoV-2 3CLpro-IN-3|HY-147804 |
| Molecular Weight | 525.42 |
| Molecular Formula | C23H21BrN6O2S |
| Canonical SMILES | CCOC(=O)C(=NNC1=CC=C(C=C1)Br)SC(=NNC2=CC=CC=C2)N=NC3=CC=CC=C3 |
| Purity | ≥98% (HPLC) |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 684 |
| Exact Mass | 524.06301 |
| Target | SARS-CoV; Bacterial; Fungal |
| XLogP3-AA | 8.8 |
